Today is September 22, 2018. All times in Eastern Daylight Time.
Novocure and Zai Lab Announce Strategic Collaboration with a License Agreement for Tumor Treating Fields in Greater ChinaST. HELIER, Jersey & SHANGHAI--(BUSINESS WIRE)--Novocure and Zai Lab announced an exclusive license agreement for Tumor Treating Fields in Greater China and a strategic development collaboration.
Tumor Treating Fields Plus Standard of Care Chemotherapy Significantly Extends Median Overall Survival by 6.1 Months in STELLAR Phase 2 Registration Trial in Mesothelioma Compared to Historical ControlST. HELIER, Jersey--(BUSINESS WIRE)--Results from Novocure's STELLAR trial in mesothelioma demonstrate a significant extension in median overall survival compared to a historical control.